Skip to content

Clinical trials

Phase 2 Idiopathic Pulmonary Fibrosis trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Phase 2 Country / region: Greece Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20171
20181
20201
20222
20233
20243
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6
Completed4
Recruiting3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
AbbVie1
Amgen1
AstraZeneca1
Biogen1
Celgene1
Contineum Therapeutics1
Genentech, Inc.1
Hoffmann-La Roche1
Modern Biosciences Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis16
Pulmonary Fibrosis5
Lung Diseases, Interstitial2
Fibrosis1
Idiopathic Interstitial Pneumonias1
Lung Diseases1
Pathologic Processes1
Respiration Disorders1
Respiratory Tract Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.